Related Experiment Video
Updated: Dec 13, 2025
12:57
Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
Published on: November 16, 2017
8.6K
Norovirus Vaccine: Priorities for Future Research and Development
Susanna Esposito1, Nicola Principi2
1Pediatric Clinic, Department of Medicine and Surgery, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy.
Frontiers in Immunology
|August 1, 2020
Summary
Developing a norovirus (NoV) vaccine is a global health priority due to widespread acute gastroenteritis outbreaks. While progress has been made, challenges remain in ensuring broad protection, efficacy across all age groups, and long-term immunity.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Norovirus (NoV) is a leading cause of acute gastroenteritis (AGE) outbreaks and sporadic diarrhea globally.
- The World Health Organization has prioritized NoV vaccine development due to its significant public health impact.
Purpose of the Study:
- To discuss the rationale, challenges, and current candidates for norovirus (NoV) vaccine development.
- To review the progress and remaining hurdles in creating an effective and safe NoV vaccine.
Main Methods:
- Review of epidemiological and immunological studies on norovirus (NoV) vaccine candidates.
- Analysis of clinical trial data and identified knowledge gaps regarding vaccine efficacy and safety.
Main Results:
- Multivalent vaccines targeting both GI and GII norovirus (NoV) genotypes show promise for broad protection.
- Significant challenges persist, including defining protection against diverse strains, efficacy in all age groups, and duration of immunity.
Conclusions:
- While progress in norovirus (NoV) vaccine development is evident, further research is crucial to address remaining safety, efficacy, and duration of immunity questions.
- Establishing an effective immunization schedule and assessing cost-effectiveness requires resolution of current knowledge gaps.
